Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.

Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. It operates through the following segments: Pharmaceuticals, Information Service, and Others. The Pharmaceuticals segment researches, develops, manufactures, and markets drugs, which are used in the fields of urology, dialysis, women's health, ophthalmology, endocrinology and metabolism. The Information Service segment offers information services to use in IT and capital investment. The Others segment includes merchandise sales and construction contractors. The company was founded on August 9, 1946 and is headquartered in Matsumoto, Japan.

Sanwa Kagaku Kenkyusho Co., Ltd. engages in the research, development, manufacture, and marketing of pharmaceuticals, diagnostics, medical and nursing care nutritionals, and healthcare products. The company also provides contract manufacturing services for pharmaceuticals. It offers products through a network of medical representatives worldwide. The company was founded in 1953 and is based in Nagoya, Japan. Sanwa Kagaku Kenkyusho Co., Ltd. operates as a subsidiary of Suzuken Co., Ltd.

Fujian Rongyi Bacteria Technology R&D Co., Ltd., established on 2011-04-25, The business scope includes edible fungus processing,to plant,Sales;Edible mushroom technology research and development,technology transfer;vegetable products[Edible mushroom products(Dried Edible Mushrooms)]and vegetable products[Dried Vegetables(Vegetable powder and products)]Production,Sales;Aquatic product processing;Marine Biotechnology Research,development and utilization;investment in agriculture;comprehensive agricultural development;Sales of prepackaged food;Self-operated and agent import and export of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Xiamen Kaierli Information Technology Co., Ltd., established on 2016-07-14, Business scope includes software development;Information system integration service;Data Processing and Storage Services;Information Technology Consulting Services;animation,comic design,make;Internet access and related services(Internet cafes not included);IC Design;Other unspecified information technology service industry(Items not subject to permit approval);other internet services(Items not subject to permit approval).

Shionogi & Co., Ltd. engages in the research, development, supply, manufacture and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan.

Xunuo Pharmaceutical (Nanjing) Co., Ltd., established on 2017-11-20, Business scope includes licensed projects:Drug import and export;Pharmaceutical commissioned production;Drug retail;Drug Wholesale;Import and export;Technology Import and Export;pharmaceutical production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Engineering and Technology Research and Experimental Development;Health Consulting Services(Does not include medical services);Domestic trade agent;Chemical product sales(No licensed chemical products);Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Manufactures and sells pharmaceuticals

Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Banyu Pharmaceutical Co. Ltd. produces and distributes pharmaceutical products. It researches, develops, manufactures, sells, and imports and exports ethical drugs in Japan. Banyu Pharmaceutical was founded in 1915 and is headquartered in Tokyo, Japan.

G.D. Searle, LLC is a wholly owned trademark of Pfizer. It is currently used mainly as a distribution trademark for various pharmaceuticals that were developed by G. D. Searle & Company (often referred to as Searle). Prior to its 1985 merger with Monsanto, Searle was a company focusing on life sciences, specifically pharmaceuticals, agriculture, and animal health.

Part of Abbott Laboratories, Hokuriku Seiyaku Co., Ltd. is a Japanese company located in Katsuyama. The firm develops, manufactures, and sells pharmaceuticals. On June 30, 2002 Abbott Laboratories acquired Hokuriku Seiyaku Co., Ltd. for $291.31 million.

Makes a variety of chemical products

Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland.

Shenyang Xinda Taikang Pharmaceutical Technology Co., Ltd., established on 2017-03-24, Business scope includes pharmaceuticals,bio-pharmacy,Drug intermediate,Chemical raw materials and products(Removal of hazardous chemicals),medical instruments,Diagnostic reagent research and development,check,technology transfer,technical consulting,Technical Services;Biotechnology,Medical Laboratory Technology,computer technology development,technology transfer,technical consulting,Technical Services;Medical information consultation.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)